Overview
Status
Active
Registry date
2022-12-16
Share capital
5,000.00 PLN
Registered address
ul. Gen. Tadeusza Pełczyńskiego 5/10, 01-471 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 79 days early.
- 202509/07/2026
- 202426/03/2025
- 202318/03/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 71.56kMedianUSD 443.52kAverageUSD 1.75m
Net profit
This companyUSD 7.88kMedianUSD 14.31kAverageUSD 129.53k
Operating costs
This companyUSD 62.91kMedianUSD 397.10kAverageUSD 1.56m
Assets
This companyUSD 65.38kMedianUSD 173.92kAverageUSD 1.02m
Industry
Authorized Representatives
Marcin Zabrotowicz – President of the Management Board
Manner of representation
Each member of the management board independently is authorised to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Endogyn Fundacja Rodzinna | 95 | $1,283.09 | 95% |
Others | 5 | $67.53 | 5% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nectar Polskasp. z o.o. | $528,123.00 | klinikametoda.pl | ||
| Astimedsp. z o.o. | $498,540.18 | astimed.pl | ||
| I. V. Clinicsp. z o.o. | $510,444.80 | ivclinic.com.pl | ||
| MAAMsp. z o.o. | $455,593.52 | urmed.pl | ||
| Saska Medsp. z o.o. | $241,826.45 | saskamed.pl | ||
| Promindsp. z o.o. | $89,181.48 | promindclinic.pl | ||
| Onkomedicasp. z o.o. | $69,344.55 | onkomedica.pl | ||
| Biocells Medicalsp. z o.o. | $11,508.17 | biocellsmedical.com | ||
| Bodyclinicsp. z o.o. | $3,758.46 | bodyclinic.pl | ||
| Regenerumclinicsp. z o.o. | $1,427.86 | regenerumclinic.pl |
FAQ
The main business activity of Endogyn focuses on specialist medical practice activities.
The company was registered in the Polish National Court Register (KRS) on December 16, 2022.
The headquarters is located at: ul. Gen. Tadeusza Pełczyńskiego 5, 01-471 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $94,364 in 2024, which is an increase of 65.2% compared to 2023.
Yes, the company recorded a net profit of $31,404 in 2024, meaning the company increased its profit by 30.2%.
The largest operating cost category falls under employee remuneration. This category amounted to $36,081 in 2024, representing 60% of all operating expenses.
Last updated: 2026-07-15